| Date | Time | Source | Announcement |
|---|---|---|---|
| 16 Apr 2002 | 02:53 PM | Holding(s) in Company | |
| 15 Apr 2002 | 03:15 PM | Appointment | |
| 09 Apr 2002 | 04:58 PM | Director Shareholding | |
| 08 Apr 2002 | 04:17 PM | Director Shareholding | |
| 04 Apr 2002 | 04:43 PM | Holding(s) in Company | |
| 03 Apr 2002 | 04:34 PM | Director Shareholding | |
| 03 Apr 2002 | 11:00 AM | Strong Sales Growth | |
| 28 Mar 2002 | 07:00 AM | Disposal | |
| 22 Mar 2002 | 09:02 AM | Tender Offer Completed | |
| 13 Mar 2002 | 03:53 PM | Merger Update | |
| 05 Mar 2002 | 05:27 PM | Annual Report and Accounts | |
| 27 Feb 2002 | 04:38 PM | Holding(s) in Company | |
| 22 Feb 2002 | 11:45 AM | Tender Offer | |
| 21 Feb 2002 | 05:04 PM | Holding(s) in Company | |
| 15 Feb 2002 | 02:45 PM | Products Update | |
| 14 Feb 2002 | 07:01 AM | Acquisition | |
| 13 Feb 2002 | 05:31 PM | Holding(s) in Company | |
| 07 Feb 2002 | 08:39 AM | Dividend | |
| 07 Feb 2002 | 07:00 AM | Final Results | |
| 21 Jan 2002 | 02:40 PM | Additional Listing | |
| 14 Jan 2002 | 04:17 PM | Announcements Dates | |
| 10 Jan 2002 | 01:00 PM | Notice of Meeting | |
| 08 Jan 2002 | 04:04 PM | Holding in Company | |
| 02 Jan 2002 | 04:36 PM | Holding in Company | |
| 19 Dec 2001 | 02:00 PM | Pre-Close Statement | |
| 17 Dec 2001 | 03:57 PM | Appointment | |
| 14 Dec 2001 | 05:19 PM | Director Shareholding | |
| 11 Dec 2001 | 01:00 PM | Pre-Close Briefing Date | |
| 07 Dec 2001 | 04:37 PM | Director Shareholding-Amend | |
| 06 Dec 2001 | 02:50 PM | Director Shareholding | |
| 30 Nov 2001 | 04:38 PM | Price Monitoring Extension | |
| 26 Nov 2001 | 04:33 PM | Director Shareholding | |
| 21 Nov 2001 | 05:08 PM | Director Shareholding | |
| 13 Nov 2001 | 04:58 PM | Holding in Company | |
| 06 Nov 2001 | 04:34 PM | Holding in Company | |
| 05 Nov 2001 | 05:07 PM | Director Shareholding | |
| 30 Oct 2001 | 01:18 PM | Holding in Company | |
| 19 Oct 2001 | 04:09 PM | Holding in Company | |
| 01 Oct 2001 | 01:00 PM | FDA Approves Dermagraft | |
| 26 Sep 2001 | 09:45 AM | Analyst visit | |
| 25 Sep 2001 | 12:19 PM | Holding in Company | |
| 31 Aug 2001 | 05:43 PM | Director Shareholding | |
| 02 Aug 2001 | 07:07 AM | Dividend | |
| 02 Aug 2001 | 07:00 AM | Interim Results | |
| 17 Jul 2001 | 03:35 PM | Holding in Company | |
| 29 Jun 2001 | 03:53 PM | Director Shareholding | |
| 25 Jun 2001 | 03:45 PM | Pre-Close Statement | |
| 22 Jun 2001 | 04:48 PM | Holding in Company | |
| 19 Jun 2001 | 12:23 PM | Notice of Briefing | |
| 07 Jun 2001 | 03:59 PM | Disposal |
Smith & Nephew is a British medical technology company that develops, manufactures, and sells medical devices. Products include arthroscopy, trauma, clinical therapy, and orthopaedic reconstruction products. Smith & Nephew's products are sold in over 100 countries, including Europe, the Americas, Asia Pacific, the Middle East, and Africa.
Smith & Nephew operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Smith & Nephew's shares are traded in London and New York, and the company is a constituent of the UK's FTSE100.
Smith and Nephew share price launched at 182p in 1988.